Fewer US men are diagnosed with low-risk prostate cancer, and more of them now choose surveillance over treatment

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis published in CANCER indicates a shift toward surveillance in response to concerns of overdiagnosis and overtreatment that have hindered screening in the recent past.

Read it at Medical Xpress ↗

← Front page